R1	Has_value Arg1:T2 Arg2:T1	
R2	Has_value Arg1:T3 Arg2:T4	
R3	AND Arg1:T3 Arg2:T5	
R4	Has_value Arg1:T7 Arg2:T8	
R5	AND Arg1:T6 Arg2:T7	
R6	Has_qualifier Arg1:T10 Arg2:T13	
R7	Has_temporal Arg1:T10 Arg2:T9	
R8	AND Arg1:T16 Arg2:T15	
*	OR T18 T17
R9	Has_temporal Arg1:T18 Arg2:T19	
*	OR T18 T21
R10	Has_temporal Arg1:T16 Arg2:T20	
R11	Has_qualifier Arg1:T11 Arg2:T13	
R12	Has_qualifier Arg1:T12 Arg2:T13	
R13	Has_temporal Arg1:T11 Arg2:T9	
R14	Has_temporal Arg1:T12 Arg2:T9	
T1	Value 8 19	18-75 years
T2	Person 3 6	Age
T3	Measurement 54 95	Left ventricular ejection fraction (LVEF)
T4	Value 96 101	â‰¤ 40%
T5	Procedure 103 107	ECHO
T6	Condition 128 149	chronic heart failure
T7	Measurement 151 155	NYHA
T8	Value 156 171	class II or III
T9	Temporal 178 199	In the past one month
T10	Temporal 235 242	history
T11	Condition 244 261	clinical symptoms
T12	Condition 244 252;266 271	clinical signs
T13	Qualifier 277 294	relatively stable
T15	Condition 334 355	chronic heart failure
T16	Procedure 321 355	treatment of chronic heart failure
T17	Observation 378 400	maximum tolerance dose
T18	Observation 363 374	target dose
T19	Temporal 401 417	for over 1 month
T20	Temporal 437 452	in last 1 month
T21	Observation 422 436	unchanged dose
T24	Post-eligibility 458 504	Understand and sign the informed consent form;
T25	Non-query-able 458 504	Understand and sign the informed consent form;
